Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys

PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of nuclear medicine 1995-08, Vol.9 (3), p.119-123
Hauptverfasser: Hayase, N, Tomiyoshi, K, Watanabe, K, Horikoshi, S, Shibasaki, T, Ohye, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 3
container_start_page 119
container_title Annals of nuclear medicine
container_volume 9
creator Hayase, N
Tomiyoshi, K
Watanabe, K
Horikoshi, S
Shibasaki, T
Ohye, C
description PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminated in the lesioned striatum. FMT-PET studies were able to detect dopaminergic terminals in both normal and hemiparkinsonian monkeys, and clearly showed a reduction in aromatic L-amino acid decarboxylase (AAAD) activities in the MPTP-lesioned striatum. These results show that FMT is promising as a PET tracer for the evaluation of central dopaminergic systems in parkinsonism.
doi_str_mv 10.1007/BF03165037
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21122418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21122418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-5a67eacb1f463f28f3d7fd7b6fb191e42df1e8a426df3264be4a540b505eaeaa3</originalsourceid><addsrcrecordid>eNpFkM9LwzAYhoMoc04v3oWePAjR_Gyzow6nwsQd5kmkpO0XF7cmNWmR_vdWNvT0fYfnfeF9EDqn5JoSkt3czQmnqSQ8O0BjqlKBU8H5IRqTKRU4oyo7RicxfhLClFRshEZKciEVHyNY-mjb4F0CtY3RDk_ra_8RdLPuk2_brhOB36iav5tt54PHC1zjtg9DykFiXfK8XC2xdVVXQpWsh5JGh4110TurXVJ7t4E-nqIjo7cRzvZ3gl7n96vZI168PDzNbhe4ZDJrsdRpBrosqBEpN0wZXmWmyorUFHRKQbDKUFBasLQynKWiAKGlIIUkEjRozSfoctfbBP_VQWzzYVQJ26124LuYM0oZE1QN4NUOLIclMYDJm2BrHfqckvzXaf7vdIAv9q1dUUP1h-4l8h_RQHLN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21122418</pqid></control><display><type>article</type><title>Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Alma/SFX Local Collection</source><creator>Hayase, N ; Tomiyoshi, K ; Watanabe, K ; Horikoshi, S ; Shibasaki, T ; Ohye, C</creator><creatorcontrib>Hayase, N ; Tomiyoshi, K ; Watanabe, K ; Horikoshi, S ; Shibasaki, T ; Ohye, C</creatorcontrib><description>PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminated in the lesioned striatum. FMT-PET studies were able to detect dopaminergic terminals in both normal and hemiparkinsonian monkeys, and clearly showed a reduction in aromatic L-amino acid decarboxylase (AAAD) activities in the MPTP-lesioned striatum. These results show that FMT is promising as a PET tracer for the evaluation of central dopaminergic systems in parkinsonism.</description><identifier>ISSN: 0914-7187</identifier><identifier>EISSN: 1864-6433</identifier><identifier>DOI: 10.1007/BF03165037</identifier><identifier>PMID: 8534583</identifier><language>eng</language><publisher>Japan</publisher><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ; Animals ; Central Nervous System Stimulants - pharmacokinetics ; Corpus Striatum - diagnostic imaging ; Corpus Striatum - metabolism ; Fluorine Radioisotopes - pharmacokinetics ; Macaca ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - diagnostic imaging ; Parkinson Disease, Secondary - metabolism ; Reference Values ; Tomography, Emission-Computed - methods ; Tyrosine - analogs &amp; derivatives ; Tyrosine - pharmacokinetics</subject><ispartof>Annals of nuclear medicine, 1995-08, Vol.9 (3), p.119-123</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c257t-5a67eacb1f463f28f3d7fd7b6fb191e42df1e8a426df3264be4a540b505eaeaa3</citedby><cites>FETCH-LOGICAL-c257t-5a67eacb1f463f28f3d7fd7b6fb191e42df1e8a426df3264be4a540b505eaeaa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8534583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hayase, N</creatorcontrib><creatorcontrib>Tomiyoshi, K</creatorcontrib><creatorcontrib>Watanabe, K</creatorcontrib><creatorcontrib>Horikoshi, S</creatorcontrib><creatorcontrib>Shibasaki, T</creatorcontrib><creatorcontrib>Ohye, C</creatorcontrib><title>Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><description>PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminated in the lesioned striatum. FMT-PET studies were able to detect dopaminergic terminals in both normal and hemiparkinsonian monkeys, and clearly showed a reduction in aromatic L-amino acid decarboxylase (AAAD) activities in the MPTP-lesioned striatum. These results show that FMT is promising as a PET tracer for the evaluation of central dopaminergic systems in parkinsonism.</description><subject>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</subject><subject>Animals</subject><subject>Central Nervous System Stimulants - pharmacokinetics</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Corpus Striatum - metabolism</subject><subject>Fluorine Radioisotopes - pharmacokinetics</subject><subject>Macaca</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - diagnostic imaging</subject><subject>Parkinson Disease, Secondary - metabolism</subject><subject>Reference Values</subject><subject>Tomography, Emission-Computed - methods</subject><subject>Tyrosine - analogs &amp; derivatives</subject><subject>Tyrosine - pharmacokinetics</subject><issn>0914-7187</issn><issn>1864-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM9LwzAYhoMoc04v3oWePAjR_Gyzow6nwsQd5kmkpO0XF7cmNWmR_vdWNvT0fYfnfeF9EDqn5JoSkt3czQmnqSQ8O0BjqlKBU8H5IRqTKRU4oyo7RicxfhLClFRshEZKciEVHyNY-mjb4F0CtY3RDk_ra_8RdLPuk2_brhOB36iav5tt54PHC1zjtg9DykFiXfK8XC2xdVVXQpWsh5JGh4110TurXVJ7t4E-nqIjo7cRzvZ3gl7n96vZI168PDzNbhe4ZDJrsdRpBrosqBEpN0wZXmWmyorUFHRKQbDKUFBasLQynKWiAKGlIIUkEjRozSfoctfbBP_VQWzzYVQJ26124LuYM0oZE1QN4NUOLIclMYDJm2BrHfqckvzXaf7vdIAv9q1dUUP1h-4l8h_RQHLN</recordid><startdate>199508</startdate><enddate>199508</enddate><creator>Hayase, N</creator><creator>Tomiyoshi, K</creator><creator>Watanabe, K</creator><creator>Horikoshi, S</creator><creator>Shibasaki, T</creator><creator>Ohye, C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>199508</creationdate><title>Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys</title><author>Hayase, N ; Tomiyoshi, K ; Watanabe, K ; Horikoshi, S ; Shibasaki, T ; Ohye, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-5a67eacb1f463f28f3d7fd7b6fb191e42df1e8a426df3264be4a540b505eaeaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</topic><topic>Animals</topic><topic>Central Nervous System Stimulants - pharmacokinetics</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Corpus Striatum - metabolism</topic><topic>Fluorine Radioisotopes - pharmacokinetics</topic><topic>Macaca</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - diagnostic imaging</topic><topic>Parkinson Disease, Secondary - metabolism</topic><topic>Reference Values</topic><topic>Tomography, Emission-Computed - methods</topic><topic>Tyrosine - analogs &amp; derivatives</topic><topic>Tyrosine - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayase, N</creatorcontrib><creatorcontrib>Tomiyoshi, K</creatorcontrib><creatorcontrib>Watanabe, K</creatorcontrib><creatorcontrib>Horikoshi, S</creatorcontrib><creatorcontrib>Shibasaki, T</creatorcontrib><creatorcontrib>Ohye, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayase, N</au><au>Tomiyoshi, K</au><au>Watanabe, K</au><au>Horikoshi, S</au><au>Shibasaki, T</au><au>Ohye, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys</atitle><jtitle>Annals of nuclear medicine</jtitle><addtitle>Ann Nucl Med</addtitle><date>1995-08</date><risdate>1995</risdate><volume>9</volume><issue>3</issue><spage>119</spage><epage>123</epage><pages>119-123</pages><issn>0914-7187</issn><eissn>1864-6433</eissn><abstract>PET imaging studies with 4-[18F]fluoro-L-m-tyrosine (FMT) in normal macaca monkeys showed selective accumulations of radioactivity in the striatum with time. In monkeys rendered hemiparkinsonian by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), FMT uptake was eliminated in the lesioned striatum. FMT-PET studies were able to detect dopaminergic terminals in both normal and hemiparkinsonian monkeys, and clearly showed a reduction in aromatic L-amino acid decarboxylase (AAAD) activities in the MPTP-lesioned striatum. These results show that FMT is promising as a PET tracer for the evaluation of central dopaminergic systems in parkinsonism.</abstract><cop>Japan</cop><pmid>8534583</pmid><doi>10.1007/BF03165037</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0914-7187
ispartof Annals of nuclear medicine, 1995-08, Vol.9 (3), p.119-123
issn 0914-7187
1864-6433
language eng
recordid cdi_proquest_miscellaneous_21122418
source MEDLINE; Springer Nature - Complete Springer Journals; Alma/SFX Local Collection
subjects 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Central Nervous System Stimulants - pharmacokinetics
Corpus Striatum - diagnostic imaging
Corpus Striatum - metabolism
Fluorine Radioisotopes - pharmacokinetics
Macaca
Parkinson Disease, Secondary - chemically induced
Parkinson Disease, Secondary - diagnostic imaging
Parkinson Disease, Secondary - metabolism
Reference Values
Tomography, Emission-Computed - methods
Tyrosine - analogs & derivatives
Tyrosine - pharmacokinetics
title Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A04%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Positron%20emission%20tomography%20with%204-%5B18F%5Dfluoro-L-m-tyrosine%20in%20MPTP-induced%20hemiparkinsonian%20monkeys&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Hayase,%20N&rft.date=1995-08&rft.volume=9&rft.issue=3&rft.spage=119&rft.epage=123&rft.pages=119-123&rft.issn=0914-7187&rft.eissn=1864-6433&rft_id=info:doi/10.1007/BF03165037&rft_dat=%3Cproquest_cross%3E21122418%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21122418&rft_id=info:pmid/8534583&rfr_iscdi=true